Clinical utilization of olaparib, a PARP inhibitor, in BRCA1-mutant metastatic acral melanoma.
Jiang R, Liang X, Tao Y, Xia R, Lei M, Jiang B, Judson-Torres RL, Zhang Y, Zhang W, Zeng H.
Jiang R, et al. Among authors: zhang w, zhang y.
Genes Dis. 2022 Dec 24;10(5):1755-1758. doi: 10.1016/j.gendis.2022.11.014. eCollection 2023 Sep.
Genes Dis. 2022.
PMID: 37492699
Free PMC article.
No abstract available.